Immusmol

Healthcare Services · France · 11-50 Employees

View Company Info for Free

Overview

Headquarters

229 Cours De L'argonne, Bordeaux, Nouvel...

Phone Number

+33 547302772

Revenue

<$5 Million

Industry

Healthcare Services Manufacturing Business Services Research & Development Medical Devices & Equipment Medical Laboratories & Imaging Centers
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
2
1

About Immusmol

Immusmol is a French biotech company specializing in the development of antibodies and immunoassays, particularly ELISA kits, for the detection and quantification of small molecules. With over 10 years of expertise, the company offers a range of products for imaging key neurotransmitters such as dopamine, serotonin, and GABA, as well as various metabolites. Their products are designed for academic researchers and biotech companies, ensuring fast global shipping through a network of distributors. Immusmol's offerings include high-sensitivity ELISA kits and dedicated immuno-staining kits to facilitate multiplexed imaging in cell cultures and tissue samples.Explore more
Immusmol's Social MediaPopular SearchesImmuSmolImmuSmol SASSIC Code 28,283NAICS Code 32,325Show more

Is Immusmol your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Healthcare Services companies

Low Activity

High Activity

Activity Insights

Immusmol is experiencing very low activity levels compared to other companies in the Healthcare Services sector.

What does this means?

Immusmol is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Immusmol.

Immusmol Tech Stack

A closer look at the technologies used by Immusmol

Top Healthcare Services Companies

Frequently Asked Questions Regarding Immusmol

What is Immusmol's official website?
Immusmol's official website is www.immusmol.com
What is Immusmol's Revenue?
Immusmol's revenue is <$5 Million
What is Immusmol's SIC code?
Immusmol's SIC: 28,283
What is Immusmol's NAICS code?
Immusmol's NAICS: 32,325
How many employees does Immusmol have?
Immusmol has 11-50 employees
What industry does Immusmol belong to?
Immusmol is in the industry of: Healthcare Services, Manufacturing, Business Services
What technology does Immusmol use?
Some of the popular technologies that Immusmol uses are: WooCommerce, Google Remarketing, WordPress.org, reCAPTCHA
How do I contact Immusmol?
Immusmol contact info: Phone number: +33 547302772 Website: www.immusmol.com
What does Immusmol do?

Immusmol is a French biotech company specializing in the development of antibodies and immunoassays, particularly ELISA kits, for the detection and quantification of small molecules. With over 10 years of expertise, the company offers a range of products for imaging key neurotransmitters such as dopamine, serotonin, and GABA, as well as various met... abolites. Their products are designed for academic researchers and biotech companies, ensuring fast global shipping through a network of distributors. Immusmol's offerings include high-sensitivity ELISA kits and dedicated immuno-staining kits to facilitate multiplexed imaging in cell cultures and tissue samples.Read More

What are Immusmol social media links?
Immusmol Linkedin page Immusmol Twitter page Immusmol Facebook page
Is Immusmol a public company?
Immusmol is private company therefore does not currently have an official ticker symbol
See more information about Immusmol

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.